AnaptysBio Inc. (ANAB)
NASDAQ · Healthcare
AnaptysBio Inc. EBITDA 2015–2025
AnaptysBio Inc. annual/quarterly ebitda history and growth rate from 2015 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- AnaptysBio Inc. ebitda for the quarter ending March 31, 2026 was -34.5 M, a 25.97% increase year-over-year.
- AnaptysBio Inc. ebitda for the twelve months ending March 31, 2026 was -148.2 M, a 75.16% increase year-over-year.
- AnaptysBio Inc. annual ebitda for 2025 was 48.5 M, a 142.38% decrease from 2024.
- AnaptysBio Inc. annual ebitda for 2024 was -114.3 M, a 30.18% decrease from 2023.
- AnaptysBio Inc. annual ebitda for 2023 was -163.8 M, a 43.05% increase from 2022.
- AnaptysBio Inc. annual ebitda for 2022 was -114.5 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
AnaptysBio Inc. EBITDA — FAQ
AnaptysBio Inc. (ANAB) ebitda over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ANAB's ebitda history?
The chart and table above show AnaptysBio Inc.'s ebitda by year and by quarter, including the growth rate.